Percutaneous transhepatic cholangiography (PTC) is a medical imaging technique used to diagnose and treat diseases of the biliary system, including gallstones, biliary strictures, and bile duct tumors. It is a minimally invasive procedure which involves the insertion of a needle into the liver to access the bile ducts for visualization. PTC can provide valuable information about the anatomy and function of the biliary system, which is essential for accurate diagnosis and treatment. In this article, we will discuss the basics of PTC, its indications, risks, and benefits.
Percutaneous transhepatic cholangiography (PTC) is a medical imaging technique used to diagnose and treat diseases of the biliary system. It involves the insertion of a needle through the skin into the liver to access the bile ducts for visualization. PTC is often used to diagnose and treat gallstones, biliary strictures, and bile duct tumors. The procedure is performed under local anesthesia and usually takes about 30 minutes to complete. During the procedure, a contrast material is injected into the bile ducts. This contrast material allows the doctor to see the bile ducts on an X-ray.
PTC is indicated in a number of situations. It is often used to diagnose and treat biliary strictures, which are narrowings of the bile ducts. It can also be used to diagnose and treat gallstones, which can cause pain and other symptoms. PTC can also be used to diagnose and treat bile duct tumors.
PTC is generally a safe procedure, but there are some risks associated with it. The most common risks include infection, bleeding, and damage to the bile ducts. There is also a risk of allergic reaction to the contrast material used during the procedure.
PTC can provide valuable information about the anatomy and function of the biliary system. This information is essential for accurate diagnosis and treatment. PTC can also be used to treat certain conditions, such as biliary strictures and gallstones. In addition, PTC is a minimally invasive procedure, which means it is less risky than more invasive procedures.
Percutaneous transhepatic cholangiography (PTC) is a medical imaging technique used to diagnose and treat diseases of the biliary system. It is a minimally invasive procedure which involves the insertion of a needle into the liver to access the bile ducts for visualization. PTC can provide valuable information about the anatomy and function of the biliary system, which is essential for accurate diagnosis and treatment. In addition, PTC can be used to treat certain conditions, such as biliary strictures and gallstones. Although there are some risks associated with PTC, it is generally a safe procedure with many benefits.
1.
Investigations may result in novel combination therapies for early-stage lung cancers.
2.
Response Duration After Stopping Enfortumab Vedotin in Bladder Cancer
3.
Oncologist Sued for Double-Billing; Pharmacy Deserts; 'She Loved Scotch and Pizza'
4.
According to a study by Amrita Hospital in Kochi, cancer mortality is rising among Indian women while declining for men.
5.
A protein with new anticancer activity has been identified
1.
Essential Oncology Tools: Risk Assessment, Telehealth, AI, and Monitoring
2.
What Is Gastrinoma? Understanding This Rare Tumor and Its Treatment Options
3.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
4.
CEUS in Endometrial Cancer: A Tool for Early Myometrial Infiltration Detection
5.
Revolutionizing Cancer Treatment: The Promise of Bevacizumab Injections
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
2.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
3.
Current Scenario of Cancer- The Incidence of Cancer in Men
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
5.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation